AGE AND AGEING-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=950876, encodeId=41079508e6c9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：两次大修，一次小修，4.29投稿，11.8接收，时间挺长的，要求较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb95458191, createdName=DeerHarbor, createdTime=Wed Mar 24 22:16:51 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090763, encodeId=e49c2090e63f5, content=8.27投稿 9.28从under review变成了awaiting decision，害怕...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb28117432, createdName=ms5000002112532097, createdTime=Wed Sep 28 09:10:07 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239996, encodeId=e98e123999646, content=under review持续三个月后，变成awaiting recommendation，这是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Sat Aug 20 17:47:22 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2171436, encodeId=284221e14367a, content=审稿速度:2.0 经验分享：2月底提交，3月初送审，4月底审稿意见回来，只有1个审稿人，意见也只有一句话说觉得研究意义不大给拒了，时运不济。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Nov 28 11:06:17 CST 2023, time=2023-11-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124677, encodeId=1a1f21246e74c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏病学;心血管 经验分享：去年10月份投，11月底给了个大修，1月初修回，2月中给了个小修，3月中修回，3月中特地为了三个单词的错误再给了小修，3月底修回，10天后显示Accept（没收到邮件，但官网看得到）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230409/6d9ebf923b0a4979ace0f0abb1273493/25b69ca55ee4420abaf2681cfca190ea.jpeg, createdBy=c06a6493840, createdName=老腰怪, createdTime=Sun Apr 09 23:37:38 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-03-24 DeerHarbor

审稿速度:1.0 | 投稿命中率:50.0
经验分享：两次大修，一次小修，4.29投稿，11.8接收，时间挺长的，要求较高。

284 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=950876, encodeId=41079508e6c9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：两次大修，一次小修，4.29投稿，11.8接收，时间挺长的，要求较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb95458191, createdName=DeerHarbor, createdTime=Wed Mar 24 22:16:51 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090763, encodeId=e49c2090e63f5, content=8.27投稿 9.28从under review变成了awaiting decision，害怕...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb28117432, createdName=ms5000002112532097, createdTime=Wed Sep 28 09:10:07 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239996, encodeId=e98e123999646, content=under review持续三个月后，变成awaiting recommendation，这是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Sat Aug 20 17:47:22 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2171436, encodeId=284221e14367a, content=审稿速度:2.0 经验分享：2月底提交，3月初送审，4月底审稿意见回来，只有1个审稿人，意见也只有一句话说觉得研究意义不大给拒了，时运不济。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Nov 28 11:06:17 CST 2023, time=2023-11-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124677, encodeId=1a1f21246e74c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏病学;心血管 经验分享：去年10月份投，11月底给了个大修，1月初修回，2月中给了个小修，3月中修回，3月中特地为了三个单词的错误再给了小修，3月底修回，10天后显示Accept（没收到邮件，但官网看得到）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230409/6d9ebf923b0a4979ace0f0abb1273493/25b69ca55ee4420abaf2681cfca190ea.jpeg, createdBy=c06a6493840, createdName=老腰怪, createdTime=Sun Apr 09 23:37:38 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-23 ms4000000037027629

投稿命中率:25.0
经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊

281 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=950876, encodeId=41079508e6c9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：两次大修，一次小修，4.29投稿，11.8接收，时间挺长的，要求较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb95458191, createdName=DeerHarbor, createdTime=Wed Mar 24 22:16:51 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090763, encodeId=e49c2090e63f5, content=8.27投稿 9.28从under review变成了awaiting decision，害怕...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb28117432, createdName=ms5000002112532097, createdTime=Wed Sep 28 09:10:07 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239996, encodeId=e98e123999646, content=under review持续三个月后，变成awaiting recommendation，这是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Sat Aug 20 17:47:22 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2171436, encodeId=284221e14367a, content=审稿速度:2.0 经验分享：2月底提交，3月初送审，4月底审稿意见回来，只有1个审稿人，意见也只有一句话说觉得研究意义不大给拒了，时运不济。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Nov 28 11:06:17 CST 2023, time=2023-11-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124677, encodeId=1a1f21246e74c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏病学;心血管 经验分享：去年10月份投，11月底给了个大修，1月初修回，2月中给了个小修，3月中修回，3月中特地为了三个单词的错误再给了小修，3月底修回，10天后显示Accept（没收到邮件，但官网看得到）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230409/6d9ebf923b0a4979ace0f0abb1273493/25b69ca55ee4420abaf2681cfca190ea.jpeg, createdBy=c06a6493840, createdName=老腰怪, createdTime=Sun Apr 09 23:37:38 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-09-28 ms5000002112532097

8.27投稿 9.28从under review变成了awaiting decision，害怕....

119 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=950876, encodeId=41079508e6c9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：两次大修，一次小修，4.29投稿，11.8接收，时间挺长的，要求较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb95458191, createdName=DeerHarbor, createdTime=Wed Mar 24 22:16:51 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090763, encodeId=e49c2090e63f5, content=8.27投稿 9.28从under review变成了awaiting decision，害怕...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb28117432, createdName=ms5000002112532097, createdTime=Wed Sep 28 09:10:07 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239996, encodeId=e98e123999646, content=under review持续三个月后，变成awaiting recommendation，这是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Sat Aug 20 17:47:22 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2171436, encodeId=284221e14367a, content=审稿速度:2.0 经验分享：2月底提交，3月初送审，4月底审稿意见回来，只有1个审稿人，意见也只有一句话说觉得研究意义不大给拒了，时运不济。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Nov 28 11:06:17 CST 2023, time=2023-11-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124677, encodeId=1a1f21246e74c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏病学;心血管 经验分享：去年10月份投，11月底给了个大修，1月初修回，2月中给了个小修，3月中修回，3月中特地为了三个单词的错误再给了小修，3月底修回，10天后显示Accept（没收到邮件，但官网看得到）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230409/6d9ebf923b0a4979ace0f0abb1273493/25b69ca55ee4420abaf2681cfca190ea.jpeg, createdBy=c06a6493840, createdName=老腰怪, createdTime=Sun Apr 09 23:37:38 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-08-20 ms8000001190739114

under review持续三个月后，变成awaiting recommendation，这是什么情况呀？

211 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=950876, encodeId=41079508e6c9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：两次大修，一次小修，4.29投稿，11.8接收，时间挺长的，要求较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb95458191, createdName=DeerHarbor, createdTime=Wed Mar 24 22:16:51 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090763, encodeId=e49c2090e63f5, content=8.27投稿 9.28从under review变成了awaiting decision，害怕...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb28117432, createdName=ms5000002112532097, createdTime=Wed Sep 28 09:10:07 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239996, encodeId=e98e123999646, content=under review持续三个月后，变成awaiting recommendation，这是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Sat Aug 20 17:47:22 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2171436, encodeId=284221e14367a, content=审稿速度:2.0 经验分享：2月底提交，3月初送审，4月底审稿意见回来，只有1个审稿人，意见也只有一句话说觉得研究意义不大给拒了，时运不济。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Nov 28 11:06:17 CST 2023, time=2023-11-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124677, encodeId=1a1f21246e74c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏病学;心血管 经验分享：去年10月份投，11月底给了个大修，1月初修回，2月中给了个小修，3月中修回，3月中特地为了三个单词的错误再给了小修，3月底修回，10天后显示Accept（没收到邮件，但官网看得到）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230409/6d9ebf923b0a4979ace0f0abb1273493/25b69ca55ee4420abaf2681cfca190ea.jpeg, createdBy=c06a6493840, createdName=老腰怪, createdTime=Sun Apr 09 23:37:38 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2019-05-11 145dece4m12(暂无昵称)

我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？

404 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=950876, encodeId=41079508e6c9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：两次大修，一次小修，4.29投稿，11.8接收，时间挺长的，要求较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb95458191, createdName=DeerHarbor, createdTime=Wed Mar 24 22:16:51 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090763, encodeId=e49c2090e63f5, content=8.27投稿 9.28从under review变成了awaiting decision，害怕...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb28117432, createdName=ms5000002112532097, createdTime=Wed Sep 28 09:10:07 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239996, encodeId=e98e123999646, content=under review持续三个月后，变成awaiting recommendation，这是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Sat Aug 20 17:47:22 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2171436, encodeId=284221e14367a, content=审稿速度:2.0 经验分享：2月底提交，3月初送审，4月底审稿意见回来，只有1个审稿人，意见也只有一句话说觉得研究意义不大给拒了，时运不济。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Nov 28 11:06:17 CST 2023, time=2023-11-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124677, encodeId=1a1f21246e74c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏病学;心血管 经验分享：去年10月份投，11月底给了个大修，1月初修回，2月中给了个小修，3月中修回，3月中特地为了三个单词的错误再给了小修，3月底修回，10天后显示Accept（没收到邮件，但官网看得到）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230409/6d9ebf923b0a4979ace0f0abb1273493/25b69ca55ee4420abaf2681cfca190ea.jpeg, createdBy=c06a6493840, createdName=老腰怪, createdTime=Sun Apr 09 23:37:38 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-11-28 lkjzlzq 来自云南省

审稿速度:2.0
经验分享：2月底提交，3月初送审，4月底审稿意见回来，只有1个审稿人，意见也只有一句话说觉得研究意义不大给拒了，时运不济。。。

27 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=950876, encodeId=41079508e6c9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：两次大修，一次小修，4.29投稿，11.8接收，时间挺长的，要求较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb95458191, createdName=DeerHarbor, createdTime=Wed Mar 24 22:16:51 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090763, encodeId=e49c2090e63f5, content=8.27投稿 9.28从under review变成了awaiting decision，害怕...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb28117432, createdName=ms5000002112532097, createdTime=Wed Sep 28 09:10:07 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239996, encodeId=e98e123999646, content=under review持续三个月后，变成awaiting recommendation，这是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Sat Aug 20 17:47:22 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2171436, encodeId=284221e14367a, content=审稿速度:2.0 经验分享：2月底提交，3月初送审，4月底审稿意见回来，只有1个审稿人，意见也只有一句话说觉得研究意义不大给拒了，时运不济。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Nov 28 11:06:17 CST 2023, time=2023-11-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124677, encodeId=1a1f21246e74c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏病学;心血管 经验分享：去年10月份投，11月底给了个大修，1月初修回，2月中给了个小修，3月中修回，3月中特地为了三个单词的错误再给了小修，3月底修回，10天后显示Accept（没收到邮件，但官网看得到）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230409/6d9ebf923b0a4979ace0f0abb1273493/25b69ca55ee4420abaf2681cfca190ea.jpeg, createdBy=c06a6493840, createdName=老腰怪, createdTime=Sun Apr 09 23:37:38 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2019-12-06 12464da8m54(暂无昵称)

已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表:
主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了

183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了

263 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=950876, encodeId=41079508e6c9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：两次大修，一次小修，4.29投稿，11.8接收，时间挺长的，要求较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb95458191, createdName=DeerHarbor, createdTime=Wed Mar 24 22:16:51 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090763, encodeId=e49c2090e63f5, content=8.27投稿 9.28从under review变成了awaiting decision，害怕...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb28117432, createdName=ms5000002112532097, createdTime=Wed Sep 28 09:10:07 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239996, encodeId=e98e123999646, content=under review持续三个月后，变成awaiting recommendation，这是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Sat Aug 20 17:47:22 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2171436, encodeId=284221e14367a, content=审稿速度:2.0 经验分享：2月底提交，3月初送审，4月底审稿意见回来，只有1个审稿人，意见也只有一句话说觉得研究意义不大给拒了，时运不济。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Nov 28 11:06:17 CST 2023, time=2023-11-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124677, encodeId=1a1f21246e74c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏病学;心血管 经验分享：去年10月份投，11月底给了个大修，1月初修回，2月中给了个小修，3月中修回，3月中特地为了三个单词的错误再给了小修，3月底修回，10天后显示Accept（没收到邮件，但官网看得到）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230409/6d9ebf923b0a4979ace0f0abb1273493/25b69ca55ee4420abaf2681cfca190ea.jpeg, createdBy=c06a6493840, createdName=老腰怪, createdTime=Sun Apr 09 23:37:38 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-04-09 老腰怪来自广东省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤心脏病学;心血管
经验分享：去年10月份投，11月底给了个大修，1月初修回，2月中给了个小修，3月中修回，3月中特地为了三个单词的错误再给了小修，3月底修回，10天后显示Accept（没收到邮件，但官网看得到）

65 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=950876, encodeId=41079508e6c9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：两次大修，一次小修，4.29投稿，11.8接收，时间挺长的，要求较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb95458191, createdName=DeerHarbor, createdTime=Wed Mar 24 22:16:51 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090763, encodeId=e49c2090e63f5, content=8.27投稿 9.28从under review变成了awaiting decision，害怕...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb28117432, createdName=ms5000002112532097, createdTime=Wed Sep 28 09:10:07 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239996, encodeId=e98e123999646, content=under review持续三个月后，变成awaiting recommendation，这是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Sat Aug 20 17:47:22 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2171436, encodeId=284221e14367a, content=审稿速度:2.0 经验分享：2月底提交，3月初送审，4月底审稿意见回来，只有1个审稿人，意见也只有一句话说觉得研究意义不大给拒了，时运不济。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Nov 28 11:06:17 CST 2023, time=2023-11-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124677, encodeId=1a1f21246e74c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏病学;心血管 经验分享：去年10月份投，11月底给了个大修，1月初修回，2月中给了个小修，3月中修回，3月中特地为了三个单词的错误再给了小修，3月底修回，10天后显示Accept（没收到邮件，但官网看得到）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230409/6d9ebf923b0a4979ace0f0abb1273493/25b69ca55ee4420abaf2681cfca190ea.jpeg, createdBy=c06a6493840, createdName=老腰怪, createdTime=Sun Apr 09 23:37:38 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-11-02 ms7000001176526874

这个under review是不是外审的意思啊

121 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=950876, encodeId=41079508e6c9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：两次大修，一次小修，4.29投稿，11.8接收，时间挺长的，要求较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb95458191, createdName=DeerHarbor, createdTime=Wed Mar 24 22:16:51 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090763, encodeId=e49c2090e63f5, content=8.27投稿 9.28从under review变成了awaiting decision，害怕...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=beb28117432, createdName=ms5000002112532097, createdTime=Wed Sep 28 09:10:07 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239996, encodeId=e98e123999646, content=under review持续三个月后，变成awaiting recommendation，这是什么情况呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7e5477221, createdName=ms8000001190739114, createdTime=Sat Aug 20 17:47:22 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2171436, encodeId=284221e14367a, content=审稿速度:2.0 经验分享：2月底提交，3月初送审，4月底审稿意见回来，只有1个审稿人，意见也只有一句话说觉得研究意义不大给拒了，时运不济。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e1d2120964, createdName=lkjzlzq, createdTime=Tue Nov 28 11:06:17 CST 2023, time=2023-11-28, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124677, encodeId=1a1f21246e74c, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤心脏病学;心血管 经验分享：去年10月份投，11月底给了个大修，1月初修回，2月中给了个小修，3月中修回，3月中特地为了三个单词的错误再给了小修，3月底修回，10天后显示Accept（没收到邮件，但官网看得到）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230409/6d9ebf923b0a4979ace0f0abb1273493/25b69ca55ee4420abaf2681cfca190ea.jpeg, createdBy=c06a6493840, createdName=老腰怪, createdTime=Sun Apr 09 23:37:38 CST 2023, time=2023-04-09, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

期刊发送的信件里需要注意几个方面的内容？

268 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务